CTSE and Alzheimer disease: Interestingly, a combination of CatE overexpression and Aβ treatment in MG6 cells induced higher secretion of sTRAIL compared with overexpression of only CatE (Figure S7h), which suggested CatE may have a greater effect on sTRAIL secretion in AD brains.